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Abstract: The fate of patients with aortic valve disease of varying degrees of severity and the relation-
ship between symptoms and haemodynamic status have been studied in 190 adults undergoing cardiac
catheterization during the last two decades. During the follow-up period, 41 patients died and 86 un-
derwent aortic valve replacement; these two events were the endpointsfor the calculation of ‘event-free’
cumulative survival. First-year survival in haemodynamically severe disease was 60% in aortic stenosis
and 96% in aortic regurgitation; in moderate and mild disease (in the absence of coronary artery dis-
ease) first-year survival was 100% in both groups. After 10 years, 9% of those with haemodynamically
severe aortic stenosis and 17% of those with severe regurgitation were event-free, in contrast to 35% and
22%, respectively, of those with moderate changes and 85% and 75%, respectively, of those with mild
abnormalities. In the presence of haemodynamically severe disease, 66% of the patients with stenosis
and 14% of those with regurgitation were severely symptomatic (history of hear (failure, syncope or New
York Heart Association class HI and IV); 23% of patients with moderate stenosis and 14% with moder-
ate regurgitation were also severely symptomatic. Only 40% of those with disease that was severe both
haemodynamically and symptomatically with either stenosis or regurgitation survived the first two years;
only 12% in the stenosis group and none in the regurgitation group were event-free at 5 years. Patients
with haemodynamically severe aortic stenosis who had few or no symptoms had a 100% survival at 2
years; the comparable figure for the aortic regurgitation group was 94%; 75% of the patients in the steno-
sis group and 65% in the regurgitation group were event-free at 5 years. In the moderate or mild stenosis
and regurgitation groups there was no mortality within the first 2 years in the absence of coronary artery
disease, regardless of symptomatic status. Haemodynamically and symptomatically severe aortic stenosis
and regurgitation have a very poor prognosis and require immediate valve surgery. Asymptomatic and
mildly symptomatic patients with haemodynamically severe aortic stenosis are at low risk and surgical
treatment can be postponed until marked symptoms appear without a significant risk of sudden death.
In severe aortic regurgitation, the decision for surgery should depend not only on symptoms but should
be considered in patients with few or no symptoms because of risk of sudden death. In the absence of
coronary artery disease, moderate aortic valve disease does not require valve operation for prognostic
reasons
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Spontaneous course of aortic valve disease
J. TURDMA, O. HESS, F. SEPULCRI AND H. P. RRAYENBUEHL
Medical Policlinic, Cardiology, University Hospital, Zurich, Switzerland
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The fate of patients with aortic valve disease of varying degrees of severity and the relationship between
symptoms and haemodynamic status have been studied in 190 adults undergoing cardiac catheterization during
the last two decades. During the follow-up period, 41 patients died and 86 underwent aortic valve replacement;
these two events were the endpointsfor the calculation of 'event-free' cumulative survival. First-year survival in
haemodynamically severe disease was 60% in aortic stenosis and96% in aortic regurgitation; in moderate and
mild disease (in the absence of coronary artery disease) first-year survival was 100% in both groups. After 10
years, 9% of those with haemodynamically severe aortic stenosis and 17% of those with severe regurgitation
were event-free, in contrast to 35% and 22%, respectively, of those with moderate changes and 85% and 75%,
respectively, of those with mild abnormalities. In the presence of haemodynamically severe disease, 66% of the
patients with stenosis and 14%> of those with regurgitation were severely symptomatic (history of heart failure,
syncope or New York Heart Association class III and IV); 23% of patients with moderate stenosis and 14%
with moderate regurgitation were also severely symptomatic. Only 40% of those with disease that was severe
both haemodynamically and symptomatically with either stenosis or regurgitation survived the first two years;
only 12% in the stenosis group and none in the regurgitation group were event-free at 5 years. Patients with
haemodynamically severe aortic stenosis who had few or no symptoms had a 100% survival at 2 years; the
comparable figure for the aortic regurgitation group was 94%; 75% of the patients in the stenosis group and
65% in the regurgitation group were event-free at 5 years. In the moderate or mild stenosis and regurgitation
groups there was no mortality within the first 2 years in the absence of coronary artery disease, regardless of
symptomatic status.
Haemodynamically and symptomatically severe aortic stenosis and regurgitation have a very poor prog-
nosis and require immediate valve surgery. Asymptomatic and mildly symptomatic patients with haemo-
dynamically severe aortic stenosis are at low risk and surgical treatment can be postponed until marked
symptoms appear without a significant risk of sudden death. In severe aortic regurgitation, the decision for
surgery should depend not only on symptoms but should be considered in patients with few or no symptoms
because of risk of sudden death. In the absence of coronary artery disease, moderate aortic valve disease does
not require valve operation for prognostic reasons.
Timing of valve replacement in chronic aortic valve the period before heart catheterization became
disease is based on the knowledge of the spon- routine1'^231. Thus, the exact haemodynamic situ-
taneous course of the disease and the risk and ation of patients included in these studies was not
outcome of the operation. Whereas there is an known. Marked changes in patient population
abundant literature on surgical results, studies on during recent decades, such as the rapid decline in
the spontaneous course of the disease are rare, incidence of rheumatic heart disease, increasing age
especially in patients who have undergone heart of the patients and increase in frequency of coron-
catheterization1'""'. Most reports on the spon- ary artery disease, make these reports even less rep-
taneous course are based solely on symptoms and resentative for the current situation. In the present
non-invasive clinical evaluation and stem from study we demonstrate the long-term course of
patients with aortic valve disease of various severity
„ , _ . _ , , . . ,, who have been evaluated by heart catheterization.
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November 1986. T h e emphasis is on the prognostic value of
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Table 1 Distribution of aortic valve disease patients according to haemodynamic
severity
No. of Seventy of the disease
Stenosis
Regurgitation
Combined lesion
patients
73
80
37
severe
39
36
11
moderate
30
36
14
mild
4
g
12
Material and methods
This study is based on clinical, haemodynamic
and angiographic data of 190 patients with aortic
valve disease, 152 men and 38 women, who under-
went heart catheterization between 1963 and 1983.
At the time of catheterization the age ranged
between 16 and 75 years (mean 43 years). This
patient population was studied retrospectively by
searching the records of our clinic between 1970 and
1983 for patients in whom heart catheterization was
performed but who were not admitted to surgery.
Operation was not carried out because either aortic
valve disease was of minor degree, or the patients
declined operative treatment or they died before a
recommended operation. We have also included
patients being operated during the 1970-1983
period but undergoing first heart catheterization
years before. We have excluded patients who
had primary myocardial disease with only mild
additional aortic valve disease, patients with
additional haemodynamically significant mitral
valve disease and patients dying a non-cardiac
death. These 190 patients represent 86% of all
available patients of our clinic.
All patients underwent right and left heart cath-
eterization and all but 7 underwent angiography. In
all but 14 patients aortic regurgitation was quanti-
fied by thermodilution. Cardiac index was deter-
mined by Fick and/or thermodilution methods and
when both methods were available the average of
the 2 values was tabulated. Aortic valve orifice area
was calculated by the Gorlin formula124'. Quanti-
tative analysis of left ventricular angiograms was
performed regularly after 1973 and thus these data
were available only in a part of patients. Coronary
arteriography was regularly performed after 1970 in
patients with angina pectoris as well as patients over
45 years of age.
All patients were classified according to their
clinical and haemodynamic findings at the time of
the first heart catheterization. The criterion for
haemodynamic severity of the disease was valve ori-
fice area for aortic stenosis (<0-9cm2 severe,
0-95-1-4 cm2 moderate, > 1-5 cm2 mild) and the
magnitude of regurgitant fraction for aortic
regurgitation (> 45% severe, 25%-44% moderate,
<25% mild). In 15 patients, all but one having
moderate or mild disease, whose valve orifice area
was not calculated mean pressure gradient was used
as a criterion for severity. A pressure over 50 mmHg
indicated severe and below 20 mmHg mild disease.
In 14 patients without thermodilution, angio-
graphic criteria for severity of aortic regurgitation
were applied. Patients having both stenotic and
regurgitant lesions of similar degree were classified
as combined aortic valve disease. Patients having
severe aortic stenosis or regurgitation accompanied
by only mild or minimal regurgitant or stenotic
lesions were not classified as combined aortic valve
disease. Classification of patients in different
groups according to the haemodynamic severity of
the disease is presented in Table 1.
FOLLOW-UP
The great majority of the patients was followed in
our clinic and 82 patients underwent a second cath-
eterization. Information about patients dying out
of hospital or being followed elsewhere were
obtained by contacting the patients' physicians and
families. Patients were followed for up to 20 years
after initial heart catheterization, mean follow-up
being 6-6 years. During the follow-up 43 patients
died and 86 underwent aortic valve surgery.
Patients undergoing valve surgery were followed
further for an average of 4 years.
STATISTICAL EVALUATIONS
Survival of the patients was calculated according
to the life table method'251 beginning with the initial
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heart catheterization. The endpoints for calculation
of event-free survival were death and aortic valve
surgery; for calculation of the effective, true sur-
vival the endpoint was only death regardless
whether aortic valve surgery was performed or not.
Additional statistical analysis was performed with
the paired Student /-test and chi-square test as
appropriate. For comparison of the actuarial sur-
vival curves the method of Peto and Pike was
applied1261.
Results
SURVIVAL
During the follow-up 43 patients died, all of them
of cardiac or probable cardiac death; 19 patients
died before recommended valve surgery could be
performed (all within 7 months after heart
catheterization), 15 refused operative treatment,
in 5 cases surgical treatment had not been
recommended and 4 died while out of our control.
Aortic valve surgery was performed in 86 patients
and all but one patient with commissurotomy
underwent valve replacement. Among additional
surgical procedures were aorto-coronary bypass
in 4 patients, various interventions on the ascend-
ing aorta in 13 and mitral valve surgery in 5 patients
because haemodynamically significant mitral regur-
gitation developed during the follow-up. Periopera-
tive mortality was 3-5% (3 patients) and during the
later follow-up 8 patients died. Modern procedures
of intraoperative myocardial protection (hypother-
mic cardioplegia) have been applied from 1975
onwards. Event-free and effective survival in
patients with aortic stenosis and regurgitation is
presented in Fig. 1. The proportion of patients with
haemodynamically severe and moderate disease
was similar in both groups (Table 1). During the
first year mortality rate was 22% in aortic stenosis
and 4% in aortic regurgitation; at 10 years 20% of
patients with stenosis and 23% of patients with
regurgitation were event-free (no death, no oper-
ation). In the aortic stenosis group none of the
patients underwent valve surgery during the first 2
years of follow-up, in aortic regurgitation 3 patients
were operated upon during the second year; effec-
tive survival after 10 years was 57% in aortic
stenosis and 76% in aortic regurgitation. This
difference in effective survival after 10 years is not
a consequence of different survival of operated
patients with aortic stenosis and regurgitation but
reflects the different first-year survival in the two
groups. Patients with combined aortic valve disease
».» AORTIC STENOSB n-73
.
 0 AORTIC REGUROITATON n-BO
— EVENT-FREE SURVIVAL
— EFFECTIVE SURVIVAL
Figure 1 Event-free and effective cumulative survival of
73 patients with aortic stenosis and 80 patients with aortic
regurgitation since the first heart catheterization. Number of
patients with complete 5 and 10 year follow-up is indicated in
each group
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Figure 2 Event-free survival in aortic stenosis and combined
aortic lesion as well as in aortic regurgitation in relation to the
initial haemodynarmc severity of the aortic valve disease.
had a first year mortality of 13-5%; none of the
patients was operated upon within the first 2 years;
10 year event-free survival was 46% and effective
survival 79%. This, at first glance, particularly
favourable survival is, however, due to a high pro-
portion of patients with haemodynamically mild
disease in this group (Table 1).
Figure 2 demonstrates event-free survival of the
patients in relation to the haemodynamic severity
of the disease. Survival curves of patients with com-
bined lesion and those with aortic stenosis were very
similar and these 2 groups are, therefore, presented
together. In the presence of haemodynamically
severe disease first year survival was 60% in aortic
stenosis and combined lesion group, and 92% in
aortic regurgitation group; at 10 years 9% of
patients with stenosis or combined lesion and 17%
of patients with regurgitation were event-free.
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Table 2 Event-free survival in patients with aortic stenosis and regurgitation in relation to initial symptoms and findings
(*** P<0001, ** P<001. * P<0 05)
Event-free survival
Aortic stenosis and combined lesion
5 year
Aortic regurgitation
10 year 5 year 10 year
NYHA class III and IV
NYHAclassIandll
With heart failure
Without heart failure
Syncope
Without syncope
Angina pectoris
No angina pectons
End-diastolic pressure > 15 mmHg
and/or cardiac index <2-5 1 min" ' m"
end-diastolic pressure < 15 mmHg
and/or cardiac index ^2-51min~'m~
22% „
76%
0% • •
68-5%
4% , „
43%
29%
73% 27%
30% .„
65%
39% „
68-5%
38%
*••
77%
0 »»»
36%
14% „
39%
24%
34%
—
52-5% .
76%
54%
*
79-5%
—
20°/.
26%
15%
32%
Within the first two years, no operation was per-
formed in either group, event-free and effective sur-
vival being thus identical for this period; at 10 years
effective survival was 35% in aortic stenosis and
combined lesion group and 68-5% in aortic regurgi-
tation group. In the haemodynamically moderate
aortic stenosis and combined lesion group, one
patient with additional coronary artery disease died
within the first year (first-year survival rate of 97%),
at 10 years 35% of the patients were still event-free.
None of these patients has been operated during the
first 3 years; 10 year survival was 85-5%. In moder-
ate aortic regurgitation none of the patients died
during the first 4 years but 3 patients were operated
during the second year; at 10 years 22% of the
patients were event-free, effective survival at that
time was 79%. In haemodynamically mild aortic
valve disease only one patient previously success-
fully operated for coarctation underwent aortic
valve replacement within the first 5 years. None of
the patients died during the follow-up in this group;
after 10 years 85% of patients in the aortic stenosis
and combined lesion group and 75% of patients
with aortic regurgitation were event-free.
Table 2 demonstrates event-free survival of the
patients with aortic valve disease in relation to
initial symptoms and findings. Patients with iso-
lated aortic stenosis and those with combined
lesions are grouped together due to similar sympto-
matic status. In aortic stenosis and combined
lesions, the presence or history of heart failure, syn-
cope, angina pectoris and serious functional limi-
tation according to New York Heart Association
classes III and IV were connected with reduced 5
and 10 year event-free survival. The highest predic-
tive value was possessed by a history of heart failure
followed by syncope and serious functional limi-
tation. In aortic regurgitation, patients in New
York Heart Association classes III and IV or with
angina pectoris had a significantly reduced 5 year
event-free survival. In aortic regurgitation, the
number of patients with the symptoms of heart fail-
ure or syncope was small, hence related survival
was not assessed. Signs of depressed left ventricular
function such as end-diastolic pressure ^ 15 mmHg
and/or cardiac index below 2-51 min"1 m~2 were
also related to reduced 5 and 10 years survival in
both groups of patients with aortic valve disease.
RELATION BETWEEN SYMPTOMS AND HAEMODYNAM1C
SEVERITY
The frequency of various symptoms in severe,
moderate and mild aortic valve disease is repre-
sented in Fig. 3. Patients with aortic stenosis and
combined lesions are again grouped together due to
very similar symptomatic status. In haemodynami-
Course of aortic valve disease 4 75
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Figure 3 Relative frequency of different symptoms in hae-
modynamically severe, moderate and mild aortic stenosis and
regurgitation (NYHA = New York Heart Association class).
cally severe aortic stenosis and combined lesions,
56% of patients were in New York Heart Associ-
ation classes III and IV; 30% had a history of heart
failure and 32% had had a syncopal attack. At least
one of these symptoms was present in 66% of the
patients with severe disease. These symptoms were
also found in patients with moderate aortic sten-
osis. Thus, 16% of patients with moderate disease
were in New York Heart Association classes III and
IV, 5% had a history of heart failure, and 9% had
had syncope; at least one of these features was pres-
ent in 23% of patients. Three of the seven patients in
New York Heart Association classes III and IV,
both patients with a history of heart failure, and one
of the four patients with syncope had additional
coronary artery disease. In mild aortic stenosis none
of the patients was severely functionally limited,
there were no heart failure symptoms but one
patient had had a syncopal attack due to complete
atrio-ventricular block. Angina pectoris was pres-
ent in 40% of the aortic stenosis patients with
haemodynamically severe, in 39% of patients with
moderate and 25% of patients with mild aortic sten-
osis and combined lesion. Dyspnoea was present in
66% of patients with severe, 41% with moderate
and 57% with mild aortic stenosis and combined
lesions.
In aortic regurgitation, only 12% of patients with
haemodynamically severe disease were in New
York Heart Association classes HI and IV, only one
(3%) had a history of heart failure and only 2 had
had a syncope. One or another of these features was
present in 14% of the entire group of patients with
severe regurgitation. The same proportion of
patients with these symptoms was found in moder-
ate aortic regurgitation. Angina pectoris was pres-
ent in a similar proportion of patients with severe
(30%) and moderate (31%) aortic regurgitation.
Dyspnoea was present in 44% of patients with
severe, in 36% of patients with moderate and 50%
of patients with mild aortic regurgitation.
Severely symptomatic patients (patients in New
York Heart Association classes III and IV as well as
patients with heart failure and syncope) with severe
aortic stenosis had a higher mean aortic pressure
gradient (69 vs 57 mmHg, NS), smaller aortic valve
orifice area (0-56 vs 0-76cm2, P<0-0\) lower car-
diac index (2-6 vs S-Slmin"1 m~2, P<001) and
higher left ventricular end-diastolic pressure (17 vs
12 mmHg, P<0-05) than asymptomatic and mildly
symptomatic patients of the same group (Fig. 4).
These group differences have little importance for
decision-making in individual patients because a
very wide overlap between the groups existed. In
haemodynamically severe aortic regurgitation
regurgitant fraction exceeded 50% in all 5 severely
symptomatic and in only 15/30 asymptomatic and
midly symptomatic patients; cardiac index was
below 2-51 min"' m"2 in 2/5 severely symptomatic
and 3/30 asymptomatic or midly symptomatic
patients; left ventricular end-diastolic pressure
exceeded 14 mmHg in 4/5 severely symptomatic
and 14/31 mildly symptomatic patients. Quantitat-
ive evaluation of left ventricular angiography was
performed in only a proportion of patients. All 7
asymptomatic or mildly symptomatic patients with
severe aortic stenosis or combined lesion had a
normal ejection fraction (> 55%) whereas severely
symptomatic patients had a wide range of ejection
fractions from 18% to 72% and only 9/21 (43%)
had a normal value. In severe aortic regurgitation
10/11 asymptomatic and mildly symptomatic
patients had a normal ejection fraction whereas in
all 4 severely symptomatic patients ejection fraction
was decreased.
THE PROGNOSTIC VALUE OF SYMPTOMS AND HAEMO-
DYNAMICS FOR SURVIVAL
In the presence of haemodynamically severe
aortic valve disease, survival of severely sympto-
matic patients (patients in New York Heart Associ-
ation classes III and IV as well as patients with heart
failure and syncope) was very different from that of
asymptomatic or mildly symptomatic patients
(patients in New York Heart Association classes I
and II) (Figs 5 and 6). In a group of 33 patients with
haemodynamically and symptomatically severe
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Figure 4 Haemodynamically severe aortic stenosis: mean aortic pressure
gradient, valve orifice area, cardiac index and left ventricular end-diastolic
pressure in severely symptomatic and asymptomatic or mildly symptomatic
patients. Mean value and statistical difference between both groups are indicated
(NS = not significant).
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Figure 5 Event-free survival in haemodynamically severe
aortic stenosis and combined lesion as well as aortic regurgi-
tation in severely symptomatic and asymptomatic or mildly
symptomatic patients.
Figure 6 Effective survival in haemodynamically severe
aortic stenosis and combined lesion as well as aortic regurgi-
tation in severely symptomatic and asymptomatic or mildly
symptomatic patients.
aortic stenosis or combined lesions, only 27% sur-
vived 2 years and only 12% were event-free at 5
years; effective survival at 5 years was 22%. In a
small group of 5 patients with haemodynamically
and symptomatically severe aortic regurgitation,
none survived 4 years. In a group of 17 asympto-
matic or mildly symptomatic patients with severe
aortic stenosis or combined lesions, none of the
patients died or was operated during the first 2
years; at 5 years 75% of them were event-free and
94% survived. In a group of 31 asymptomatic or
midly symptomatic patients with severe aortic
regurgitation, 2 sudden and otherwise unexpected
deaths occurred within the first 2 years (2 year sur-
vival of 94%) and at 5 years effective survival was
90% and was event-free in 64%.
In the group with moderate aortic disease, 15
patients, 10 with aortic stenosis or combined
lesions and 5 with aortic regurgitation, were
severely symptomatic. Only one patient with
additional coronary artery disease died within the
first follow-up year. There was no death in this
group within the first 4 years. In the asymptomatic
and mildly symptomatic group, none of the patients
died but 27% underwent valve surgery within 5
years.
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MODE OF PROGRESSION
During the follow-up 82 patients underwent a
second catheterization. The New York Heart
Association class and the most relevant haemo-
dynamic data at the first and second catheterization
are presented in Table 3. The second catheterization
was usually performed because of symptomatic or
haemodynamic deterioration. Thus, at the second
catheterization all but 8 patients were in a higher
New York Heart Association class and in all 3
patient groups there was a significant increase in
mean New York Heart Association class. In a
group of 64 patients followed noninvasively there
was no significant change in New York Heart
Association class from the initial to the last examin-
ation. Between the first and second heart catheter-
izations there was a significant increase in mean
pressure gradient and decrease in valve orifice area
in the aortic stenosis and combined lesions group as
well as significant increase of the regurgitant fraction
in aortic regurgitation. In all 3 groups, left ventricu-
lar end-diastolic pressure increased significantly
whereas the decrease in cardiac index, present in all
3 groups, did not reach the level of statistical signifi-
cance. In the aortic stenosis group at second cath-
eterization 2 patients showed a haemodynamically
significant aortic regurgitation but none developed
significant mitral regurgitation. In the aortic regur-
gitation group, no haemodynamically significant
stenotic lesion became manifest but 4 patients
developed an aneurysm of the ascending aorta and
another 4 mitral regurgitation. In the patients with
a combined lesion, the severity of stenosis increased
in all 16 patients, the regurgitant fraction increased
in 11 and decreased in 4 patients. The rate of pro-
gression of the aortic valve disease was not predic-
table in individual cases because even within 2 to 3
years, severe aortic stenosis or regurgitation
occurred in previously moderate disease whereas
even after 10 years some patients with severe disease
showed no progression. In aortic stenosis, patients
with haemodynamically severe disease usually had
the second catheterization earlier than those with
moderate disease (77 months vs 89 months) but
there was a wide overlap between the two groups.
CORONARY ARTERY DISEASE
Seventeen patients had or developed coronary
artery disease (stenosis over 50%) during the follow-
up period. Isolated aortic stenosis was present in 12
patients (16% of all patients with aortic stenosis),
combined lesions in 3 (8% of entire group with com-
bined lesion) and in 2 aortic regurgitation (2-5% of
the entire group). Despite moderate or severe aortic
valve disease 4/17 (24%) patients were free of
angina pectoris. In aortic stenosis, the only group
with a relevant number of patients with coronary
artery disease, 50% of patients with additional cor-
onary artery disease died within the first follow-up
year and only 20-5% were event-free at 5 years. In
aortic stenosis without coronary artery disease only
16% died during the first year and 60% were event-
free at 5 years.
VALVE ENDOCARDITIS
During the follow-up, 6 patients had acute endo-
carditis, the overall incidence of endocarditis being
0-53% per patient-year. One patient died during the
acute phase of endocarditis, 5 were successfully
treated but rapid deterioration of the haemody-
namic and symptomatic status ensued and within
one year after endocarditis, all 5 patients under-
went valve replacement. In addition to aortic valve
replacement, mitral valve surgery was carried out in
two cases.
Discussion
Today, studies on the true, natural course of
aortic valve disease cannot be performed because
patients developing severe, symptomatic disease are
admitted for surgery. Thus reports have concerned
either patients who declined surgery or died before
operation110'"-28-291 or the survival of patients with
less advanced disease followed until operation
[3,5-8,3o,3ii Even here some reservation about studies
based solely on symptomatic status and clinical
signs is in order because haemodynamic severity
and possible additional heart disease such as coron-
ary artery disease may be inaccurately assessed1'51.
The purpose of our study was to assess the fate of
patients with aortic valve disease of various degrees
of severity during the last two decades and to
evaluate the relation between symptoms and hae-
modynamic status. Hence, only patients under-
going heart catheterization were included and their
outcome was evaluated from the time of initial
invasive examination until death or cardiac surgery.
Thus, haemodynamic and clinical status at the
beginning of the study were clearly defined and
because follow-up data were available in 86% of the
patients, the presented data can be regarded as
representative of experience in our clinic.
Some drawbacks of such a study should not be
overlooked. Aortic valve disease is not very fre-
quent and heart catheterization as an invasive and
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potentially dangerous procedure is performed
usually only in patients who are candidates for sur-
gical treatment or where discrepancies between the
history, symptoms and objective clinical findings
require assessment of true haemodynamic situ-
ation. Thus, a relative long period of time elapsed
until a sufficient number of patients was obtained;
medical and surgical treatment has changed con-
siderably during this period. The number of symp-
tomatic patients in mild and probably also in
moderate aortic valve disease group is too high and
not representative for the whole population of these
patients due to our sampling modus. Patients dying
before recommended operation represent some sort
of a 'spontaneous' negative selection and their
inclusion in the study tends to magnify the true
death risk in the absence of surgery.
In this study, the outcome of the patients is pre-
sented by actuarial methods in two different ways.
Patient survival in the absence of death and oper-
ation was labeled 'event-free'. Here death and oper-
ation were regarded as identical events. A similar
type of data presentation has been also applied in
other studies'22-231. Additionally, the true outcome of
the patients was also presented and called effective
survival. Here, patients were not withdrawn from
the follow-up at the time of cardiac surgery but their
outcome after operation was further pursued.
Patients undergoing aortic valve replacement are
not restored to normal health but remained
exposed, apart from the currently very small opera-
tive risk, to the morbidity and mortality risk directly
related to artificial valves such as thromboembo-
lism, endocarditis and mechanical failure of the
prosthesis.
Aortic stenosis as compared to aortic regurgi-
tation is generally regarded as a more serious disease
with a rapid progression and bad survival once
symptoms occur132"34'. In some aspects our data are
at variance with this opinion. For a given haemo-
dynamic severity, a much higher proportion of
patients in the stenosis than in the regurgitation
group is severely symptomatic and functionally dis-
abled but survival of patients with haemodynami-
cally and symptomatically severe disease is in both
groups similar. Asymptomatic and mildly sympto-
matic patients with severe disease as well as patients
with moderate and mild disease had also a similar
long-term event-free survival. Thus, in our experi-
ence the proportions of patients surviving 10 years
do not differ significantly. These data demonstrate
that any comparison between stenotic and regurgi-
tant aortic valve lesion is only valid if patients with
similar haemodynamic and symptomatic status are
concerned. Outcome of the patients with combined
stenotic and regurgitant lesions is quite similar to
that of isolated stenosis; thus these two patients
group were evaluated together.
In addition to haemodynamic severity of the dis-
ease, the degree of functional disability and sympto-
matic status emerged as predictive variables for
survival in aortic valve disease. The presence or his-
tory of heart failure, syncope and severe functional
limitation according to New York Heart Associ-
ation classes III and IV should be regarded in aortic
stenosis as well as in aortic regurgitation as har-
bingers of poor outcome. Our data resemble closely
previously reported ones (Tables 4-6). These symp-
toms, usually associated with haemodynamically
severe disease, can also be present in certain patients
with only moderate or even mild disease121'5135'361. In
the majority, additional coronary artery disease is
the cause for this discrepancy but one should not
forget that under certain circumstances such as
vigorous sporting activity or complete atrio-
ventricular block, syncopal attacks can occur
even in aortic stenosis of minor degree. Psychical
embarrassment and fear, especially in patients con-
fronted recently with their own cardiac disease
and also the tendency for aggravation in patients
who desire a secondary gain can easily lead to
exaggeration of complaints. The assessment of true
functional capacity by bicycle ergometry is indis-
pensable in such cases. In the absence of coronary
artery disease, there is no need for immediate
surgery regardless of symptomatic status.
Even in the presence of haemodynamically
severe, disease, one third of the aortic stenosis and
85% of the aortic regurgitation patients were
asymptomatic or mildly symptomatic. It is well
known that patients with aortic stenosis and
especially regurgitation can remain asympto-
matic in spite of severe haemodynamic impair-
menj.|i,i5j3j7j8] j n asymptomatic and mildly
symptomatic patients signs of haemodynamic
severity of the disease such as the pressure gradient,
valve orifice area and the regurgitant fraction as
well as left ventricular function variables such as
end-diastolic pressure, cardiac index and ejection
fraction were usually less impaired than in severely
symptomatic patients but predictive value of these
variables in individual cases is minimal due to the
large overlap between the two groups. For clinical
decision-making, a combination of haemodynamic
severity variables and symptomatic status was very
helpful. In haemodynamically and symptomatically
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Table 4 Mean survival in aortic stenosis after onset of angina.
Author
Contratto"1 '
Mitchell"15
Olesen1141
Bergeron"51
Talreda""
Blondeau11"
Anderson'1"
Loogen'1"
Rossi31'
Period of study
1913-1935
1913-1952
1933-1949
1943-1952
1948-1959
1949-1964
< 1961
1960-1970
Review 1968
Mr. r\f -
patients
180
37
42
100
60
88
100
41
—
syncope and congestive heart failure
Angina
3-3
40
4-7
20
4-4
4-5
3-5
40
Mean survival (years)
Syncope
0-8
30
3-2
2 0
3-8
3-1
30
Congestive heart
failure
0-5
1-9
10
10
2-8
1-3
2-2
20
Table 5 Actuarial survival in aortic stenosis in relation to New York Heart Association classification
Author
Frank'"*
Rapaport | ! ! )
Munoz"21
Haerten1""*
Horstkotte |B |*
ChiznerM*
Schwarz"1'*
Turina*
Period of study
1954-1972
1955-1975
1964-1974
1967-1976
1968-1981
< 1978
1975-1982
1963-1983
No. of
patients
15
42
43
35
35
42
28
110
NYHA class -
I—HI
various
II-IV
III-IV
III-IV
7
III-IV
I—II
III-IV
Actuarial survival
2 year
85%
56%
98%
39%
46%
52%
76%
99%
31%
5 year
52%
38%
64%
17%
18%
—
76%
22%
NYHA = New York Heart Association
'Studies in which heart catheterizations were performed
Table 6 Actuarial survival in aortic regurgitation in relation to severity of the disease or symptomatic status
Author
B l a n d ^
Massed"
Hegglin13"
Loogen1771
Rapaportp3>
Haerten1""*
HorstkotteP"*
Schwarz"')*
Turina*
Period of study
1921-1943
<1966
review 1968
1960-1970
1955-1975
1967-1976
1968-1981
1975-1985
1963-1983
No. of
patients
87
14
—
18
35
30
25
40
80
Severity of disease
'High degree*
CHF
CHF
Angina
CHF
Various
NYHA III-IV
NYHA III-IV
NYHA II-IV
NYHA I—II
NYHA III-IV
Actuarial survival
2 year
7%
38%
85%
11%
82%
54%
51%
92%
93%
57%
5 year
76%
—
15%
45%
(first year)
75%
37%
38%
66%
73%
29%
C H F = congestive heart failure, NYHA = New York Heart Association class
*Studies in which heart catheterizations were performed
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severe aortic stenosis as well as in regurgitation,
immediate aortic valve surgery should be per-
formed. Any delay in surgical treatment can have
deleterious impact on survival. High mortality in
patients waiting for aortic valve surgery is a well
known but seldom reported problem'27-28'38"401. Dur-
ing the 1970-1982 period, mortality rate in patients
waiting for aortic valve replacement was 3-9% with
average heart catheterization-operation delay of 2-6
months whereas during the same period operative
mortality was only 2-5%. The majority of patients
who died before operation had aortic stenosis but
premature death also occurred in aortic regurgi-
tation'20-27-381. Less clear is the situation in asympto-
matic and mildly symptomatic patients with severe
disease. In our cohort with aortic stenosis or com-
bined lesions, none of the patients died or required
operation within the first 2 years after heart cath-
eterization. Even after 5 years, 75% of them were
event-free. However, sudden and unexpected death
in asymptomatic or mildly symptomatic patients
with aortic stenosis has been reported'1-32-411. In
aortic stenosis, sudden death is responsible for
about 20% of all death cases and occurs in the great
majority of patients only during the late stage of the
disease in severely symptomatic patients''3'16-17-32-411.
It has been estimated that only 3-5% of all sudden
death cases occurred in asymptomatic patients'321.
Because such a small but definitive risk of sudden
death in asymptomatic patients with severe aortic
stenosis exists, aortic valve surgery is recommended
even for asymptomatic children with severe sten-
osis'421. There is, however, an important difference
of surgical treatment of aortic valve disease in
children and adults. In children aortic commis-
surotomy, today an operation with minimal mor-
tality and without postoperative procedure related
morbidity, is usually performed. In adults, aortic
valve replacement is required, an operation which
has some small mortality risk even when performed
by experienced surgeons and, more importantly, a
persistent postoperative morbidity and mortality
risk related to the prosthetic valve. In our experi-
ence the risk of delayed operation in asymptomatic
and mildly symptomatic patients with severe aortic
stenosis is minimal and does not justify immediate
valve replacement. Recently an identical opinion
was expressed based on the result of a follow-up
study in patients re-evaluated non-invasively by
Doppler technique1431. In aortic stenosis, in contrast
to aortic regurgitation, the risk of aortic valve
replacement in patients with poor left ventricular
function in the absence of coronary artery disease
is not necessarily increased and an improvement
of left ventricular function can be expected post-
operatively in the majority144-451.
In aortic regurgitation, the situation is even more
complex. Only a minority of patients are severely
symptomatic in the presence of haemodynamically
severe disease. Severely symptomatic patients have
a grim prognosis without operation and even after
successful operation their long-term results may be
poor138-46"*81. That these patients should be operated
upon as soon as possible is not questioned'48-491.
Within the first 2 years, we lost two asymptomatic
patients with severe regurgitation from sudden and
unexpected death, and even at 5 years event-free
and effective survival was lower than in the corres-
ponding aortic and stenosis group. During recent
years, an intensive search for variables predictive of
unsuccessful postoperative survival in aortic regur-
gitation has been initiated because the long-term
results of operation were not entirely satisfactory
when only severely symptomatic patients were
referred to surgery138'46-481. None of the rec-
ommended non-invasive and invasive variables has
been widely accepted. In our clinic, encouraged by
low operative and late mortality and worried by the
possibility of sudden death before operation, we
today suggest valve replacement even in asympto-
matic patients when marked dilatation of the left
ventricle is present and the shortening variables
are decreasing. As measures of left ventricular
dilatation echocardiographic end-diastolic and end-
systolic diameters over 75 and 55 mm respectively
and an end-diastolic volume index over 200 ml m ~2
are used. With this policy, we have lost no patient
before operation during the last 10 years and the 5
year postoperative survival has exceeded 90%(50'.
The rate of progression of aortic valve disease in
asymptomatic and mildly symptomatic patients as
well as in patients with moderate disease is scarcely
predictable. Although, in our aortic stenosis group,
patients with more advanced disease were coming
to operation earlier than those with less advanced
disease, a large over-lap between the two groups
made any predictability in individual cases imposs-
ible. Within 2 to 3 years a previously moderate sten-
osis or regurgitation can become symptomatically
and haemodynamically severe; on the other hand
patients with severe disease can remain asympto-
matic for 10 and more years. A similar experience
has been reported by others'5"91. These observations
underline the need for regular follow-up examin-
ations of patients with severe or moderate aortic
valve disease, not only by clinical means but also by
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modern noninvasive methods because worsening of
left ventricular function is not always preceded by
worsening of the symptomatic status. Patients
should be urged to report new symptoms such as
presyncopal attacks and dizziness or a decrease
of working or sport capacity. In mild aortic valve
disease within the first 5 years after diagnosis no
close surveillance is required for patients in a stable
condition. A rapid progression of aortic stenosis
has been occasionally reported but was always
preceded by symptomatic deterioration'6-531.
The presence of additional coronary artery
disease influences the outcome of patients con-
siderably, regardless of the severity of aortic valve
disease. Angina pectoris is an unreliable indicator
of the presence of coronary artery disease because
only a minority of angina patients had coronary
lesions and on the other hand some 20% to 25% of
coronary artery disease patients are free of
angina'5'1. This observation underlines the import-
ance of coronary arteriography in aortic valve
disease. Patients in whom additional coronary
artery disease is suspected on clinical grounds,
patients above the age of 40 as well as patients with
marked risk factors should undergo coronary
arteriography.
Patients with aortic valve disease have a risk of
infective endocarditis which amounts to 0-5% per
patient-year. Although in the acute phase of the
disease the risk of mortality was small, the outlook
of these patients is compromised due to rapid
deterioration of valve function even after successful
antibiotic treatment. Close surveillance and re-
evaluation of valve function after infective endocar-
ditis is required, regardless of actual symptoms.
Summing-up our experience, it is evident that
haemodynamically and symptomatically severe
aortic stenosis and regurgitation have a very poor
prognosis and require immediate valve surgery.
Asymptomatic and mildly symptomatic patients
with severe aortic stenosis are at low risk and surgi-
cal treatment can be postponed until marked symp-
toms appear without a significant risk of death. In
severe aortic regurgitation, the need for surgery is
not dependent only on symptoms but should be
considered even in asymptomatic or mildly sympto-
matic patients with massively enlarged hearts
because of the risk of sudden and unexpected death.
In the absence of coronary artery disease, moderate
aortic valve disease does not require operation for
prognostic reasons. The rate of progression of
severe and moderate aortic valve disease is scarcely
predictable and these patients require continuous
and close surveillance. In mild aortic valve disease
within the first 5 years after diagnosis, frequent
follow-up examinations of patients in stable clinical
condition are not needed.
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